CONCENTRO II CRT-D
FDA premarket approval P010031/S125 · decided 2008-10-23
Approval details
- PMA number
- P010031
- Supplement
- S125
- Supplement type
- Real-Time Process
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- CONCENTRO II CRT-D
- Generic name
- Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D)
- Applicant
- Medtronic Cardiac Rhythm Disease Management
- Date received
- 2008-09-24
- Decision date
- 2008-10-23
- Days to decision
- 29 days
- Decision code
- APPR
- Product code
- NIK
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Mounds View, MN
- Statement
- APPROVAL TO IMPLEMENT A DESIGN CHANGE TO ADD THREE NEW"INTERMEDIATE-FEATURE" MODELS (CONCERTO II MODEL CRT-D D274TRK. VIRTUOSO II ICD MODEL DRD274DRG AND MODEL VR D274VRC) TO THE APPROVED GEN 2 CONSULTA/SECURA/ MAXIMA II FAMILYOF DEVICES (CONSULTA CRT-D D224TRK, MAXIMO II CRT-D D284TRK. SECURE VR D224VRC,MAXIMO II DR D284DRG, AND MAXIMO II D284 VRC SUBMITTED UNDER P01003I/S084 ANDP980016/S114, APPROVED MARCH 17, 2008).
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.